News About: Pharm. Industry
Bayer HealthCare’s Xarelto approved in Korea
Bayer HealthCare’s Xarelto approved in Korea
The Korea Food and Drug Administration granted on April 13 Bayer HealthCare marketing authorization for the anticoagulant Xarelto (rivaroxaban), taken as one tablet, onc...
Dong-A, Asahi Kasei join forces over Flivas
Dong-A Pharmaceutical announced on April 15 that it has entered into an exclusive license agreement Asahi Kasei Pharma in Japan, granting Dong-A to develop and sales of naftopidil, an agent for the treatment of benign...
Hanmi releases smoking cessation treatment
Hanmi Pharm says it has launched a sustained release formulation of bupropion HCl 150 mg as a smoking cessation aid, intended to be taken once a day.
Originally marketed as an anti-depressant drug, bupropion is ava...
Hyundai Pharm launches once-daily escitalopram formulation
Hyundai Pharm said on April 15 it launched an once-daily oral escitalopram tablet, aiming to boost sales in the local market.
The company is seeking to expand its presence in the local antidepressant medication mar...
Drug agency to look into foreign drug makers
The nation's food and drug watchdog is considering embarking on looking into the discovery of asbestos-containing talc in medicines produced by foreign-invested pharmaceutical firms.
During the session of the parli...
Zydena debuts in Russia
Dong-A Pharmaceutical says its erectile dysfunction drug Zydena (udenafil) has been recently launched by Valenta in Russia.
Dong-A signed an agreement with Valenta (formerly OTECHESTVENNYE JSC), one of Russia’s lar...
Ilsung in race for anti-obesity drug market
Ilsung Pharm announced an ambitious target for its recently launched Reductra 15 capsule, sibutramine generic product
Ilsung said the company aims to take up a bigger market share of Reductra in the first year of m...
Choong-wae, Kaken enter into exclusive agreement for marketing of butenafine hydrochloride cream
Choong-wae Shinyak, an affiliated company of Choongp-wae Holdings and Kaken Pharmaceutical Co. announced on April 13 that they have concluded a basic agreement on the exclusive marketing in Korea by Choong-wae of topi...
Asbestos-free medicines will be released in 15 days
Pharmaceutical firms are busy replacing talc-tainted medicines with asbestos as the government banned the sales of 1,111 medicinal products on April 9.
“It will take about 15 days to replace older medicines with ne...
Drugmakers face weaker won
It is a challenging time for leading domestic pharmaceutical firms – Dong-A Pharm, Yuhan Corporation and Daewoong Pharm - to cope with the won's weakness against major currencies.
“The hike of raw material prices a...
